However, to our knowledge, the requirement of MuRF1 has never been tested in cancer-induced muscle wasting, which represents a completely distinct atrophy condition in that it is the only condition in which atrophy is driven by the presence of a tumor. The gene discussed is TRIM63; the disease is neoplasm.